Navigation Links
NW Bio Receives Regulatory Decision That Will Enable Its Phase III Brain Cancer Trial To Proceed In Germany
Date:8/9/2013

BETHESDA, Md., Aug. 9, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO)(NW Bio), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that it has received a decision from the German regulatory agency (the Paul Ehrlich Institute, or PEI) under which the Company's Phase III clinical trial will be able to proceed in Germany after the Company makes three modifications, none of which affect the body of the trial or the bases for seeking product approval.

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

Two of the three modifications directed by the PEI involve modest textual matters, as follows: 

  • One of the eligibility criteria for the trial is that patients must have adequate bone marrow function, since the immune cells with which DCVax is made are obtained through a leukapheresis blood draw.  Currently the eligibility criteria set a general standard for bone marrow function, and identify a specific quantitative measure as an example ("e.g.,").  The PEI has directed that the "e.g.," be removed and that the same quantitative measure be made into a requirement rather than an example of the requirement.
  • Certain information about the risks and benefits of the DCVax treatment is currently contained in one of the key clinical documents (the Investigator's Brochure).  The PEI has directed that the same information also be added into the trial Protocol document.

The third modification involves dropping an extra arm of the trial which is gathering data on patients who do not meet the eligibility criteria for enrollment in the body of the trial which will form the basis for any product approval decision.

The extra arm of th
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. The Center for Ultrasound Research and Education (CURE) Receives Institutional Accreditation from the Accrediting Bureau of Health Education Schools
2. Henry Schein Chairman Of The Board & CEO Receives Centennial Recognition Award For Extraordinary Commitment To The National Dental Association
3. Kinex Receives Research Support from the Hong Kong Innovation and Technology Commission (ITC)
4. Avion Pharmaceuticals, LLC, receives top accolades for trade and marketing achievements at the 11th Annual American Business Awards (The "Stevie Awards")
5. Convergence Pharmaceuticals Receives Orphan-Drug Designation for Nav1.7 Blocking Pain Drug CNV1014802
6. IntelligentMDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay
7. Signature Therapeutics Receives BrIDGs Award to Advance Its Abuse-Deterrent Oxycodone, PF614
8. Cepheid Receives FDA Market Authorization for Xpert MTB/RIF
9. Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
10. RxSafetyMatters Receives 2013 Communicator Award for its Mobile Site
11. Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
(Date:8/29/2014)...  In part four of a blog ... as a strategic asset, Mary Baxter, MBA, RPh ... Health,s Innovation Delivery Solutions business, discusses how expanding patient ... and patients. "Every hospital pharmacist knows that ... job in a value-based healthcare world," Baxter says. "For ...
(Date:8/29/2014)... , Aug. 29, 2014  Pacific Medical Data ... new website design . The main website, along ... showcases the company,s new services and content relevant to ... a new streamlined design, viewers can now better understand ... health care practices and create a more visible platform ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4PMDS Announces New Website 2
(Date:8/30/2014)... According to Bloomberg , U.S. ... Takeda Pharmaceutical Co. and Eli Lilly & Co. to ... the drugmakers concealed information about a risk of bladder ... Allen v. Takeda Pharmaceuticals North America Inc. (12-cv-00064), was ... Louisiana (Lafayette).* , According to Bloomberg, Takeda and Lilly ...
(Date:8/30/2014)... CA (PRWEB) August 30, 2014 Ticket Down ... vs. Chile exhibition match next Saturday at Levi's Stadium. ... for diehard soccer fans in the United States due to the ... in just about every major city. Many of these games ... in Brazil this past summer. , Levi’s Stadium is a brand ...
(Date:8/30/2014)... OH (PRWEB) August 30, 2014 United Theological ... first fully online degree, the Master of Theological Studies (MTS). ... in 2-3 years, is designed for students who wish to ... their understanding and capacity to serve the Church and community. ... degree, but now they can attend classes from any location ...
(Date:8/30/2014)... Patients suffering from vitiligo can now discover ... review published by Daily Gossip. , Vitiligo is ... is no wonder that numerous sufferers search for an ... is one of the most appreciated such methods at ... stop the spread of this disorder immediately, while completely ...
(Date:8/30/2014)... 2014 Daily Gossip magazine reveals in ... and panic attacks under control with a simple and ... describes this new method as an anxiety recovery ... and overcome general anxiety related disorders. , What ... fact that it can be accessed by users from ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Decision to Uphold $9 Billion Actos Award 2Health News:Mexico vs. Chile Tickets at Levi's Stadium in Santa Clara, CA: TicketDown.com Offers Promo Code for Mexico vs. Chile Exhibition Game on September 6th 2Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Natural Vitiligo Treatment Review Exposes Fast Method for Skin Repigmentation 2Health News:Panic Away Review Reveals New Natural Remedy for Anxiety Patients 2
... follicular lymphoma who continue on maintenance rituximab therapy ... who do not receive this treatment, according to ... 10 online issue of the Journal of ... with follicular lymphoma respond to initial therapy but ...
... PAUL, Minn., Feb. 10 The Minnesota Nurses Association ... agreement which addresses working conditions during emergency response situations. ... ensure adequate Registered Nurse staffing, the health and safety ... of a natural disaster, catastrophic event, pandemic illness or ...
... Researchers from Penn Medicine announced today the results ... of VRX496 at the 16th Conference on Retroviruses and ... gene therapy product being investigated for the treatment of ... to twelve subjects prior to a controlled scheduled treatment ...
... ASPS, Nearly 15-Million U.S. Working Women Considering Cosmetic ProceduresARLINGTON HEIGHTS, ... news of increasing layoffs, straining economic times, and a belief ... are looking at cosmetic medical procedures to give them a ... compiled by the American Society of Plastic Surgeons (ASPS) of ...
... rate in North Carolina may mimic rest of nation, , , TUESDAY, ... the rate of chronic low back pain has more than doubled ... authors say might reflect what,s happening in the country as a ... said Dr. Timothy S. Carey, a professor of medicine at the ...
... Feb. 10 A news conference to announce the ... to be conducted at UofL and Jewish Hospital will ... The location will be the Abell Administration Center second ... Health Sciences Campus.Speakers will include UofL President James Ramsey; ...
Cached Medicine News:Health News:Rituximab maintenance therapy improves survival in patients with relapsed follicular lymphoma 2Health News:Minnesota Nurses Association and Allina Hospitals and Clinics Forge Emergency Preparedness Agreement 2Health News:Penn Medicine presents HIV gene therapy trial data at CROI 2009 2Health News:Video: Women in the Workforce Link Cosmetic Surgery to Success 2Health News:Chronic Low Back Pain Is on the Rise 2Health News:Chronic Low Back Pain Is on the Rise 3
The NexGen CR femoral component is intended for patients who, in the physician's judgement, have good bone stock and whose ligaments provide adequate mediolateral, anteroposterior, and varus/valgus s...
Primary knee system, symmetrical in design....
Cruciate retaining, posterior stabilized and constrained components....
Maximum contact. Minimum wear. Outstanding results....
Medicine Products: